MTS Awarded Contracts Valued At $2.5 Million For New Electric Systems

EDEN PRAIRIE, Minn., Nov. 10, 2020 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced new awards for two electrically actuated systems totaling $2.5 million in contractual value. MTS will utilize electric technologies to design an improved helicopter pilot training system, featuring more... Read more

Introducing “Chemicals Informatics”: Software to Streamline New Product Research in the Chemical Industry

Tokyo, November 10, 2020 – Hitachi High-Tech Corporation today announced that Hitachi High-Tech Solutions Corporation (President: Masahiro Taniguchi / Hitachi High-Tech Solutions) is launching Chemicals Informatics – a new piece of software designed to help bring new high-value-added materials to market faster, as research and development (R&D) processes in the chemical sector has become more... Read more

New England Biolabs® broadens its Monarch® portfolio with high molecular weight (HMW) DNA extraction kits for long-read sequencing

New additions provide genomics researchers with improved extraction methods for ultra HMW DNA, with reduced time and increased purity, from a wide variety of biological samples. IPSWICH, MA (November 10, 2020): New England Biolabs (NEB®) today released two high molecular weight (HMW) DNA extraction kits — the Monarch HMW DNA Extraction Kit for Cells &... Read more

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 9, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 QuantiVacTM ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1... Read more

Roche to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting

Basel, 5 November 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data for its approved and investigational medicines will be presented at the all-virtual 62nd American Society of Hematology (ASH) Annual Meeting and Exposition from 5 – 8 December 2020. Eleven Roche medicines will be featured in more than 80 abstracts,... Read more